Vaxcyte, Inc. Insider Trading

PCVX

Last 12 months

Insiders sold $12.7M and bought nothing on the open market.

92% of the selling was scheduled in advance under 10b5-1 plans. SVP, Finance Elvia Cowan sold 557K on Dec 23, 2025, 46% of their stake, outside a plan. The last open-market buy by an executive or director was in Jun 2020.

Net open-market

−$12.7M

0 buys · 25 sales

Under a 10b5-1 plan

92%

of the value sold

Insiders who bought / sold

0 / 5

executives and directors

Last open-market buy

Jun 2020

Jun 16, 2020

Get an email when PCVX's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Nov 2	Elvia Cowan SVP, Finance & CAO	Sold10b5-1 plan 2 parts	3,000	$60.92 average	183K	9.7%	Form 4
Nov 2	Jim Wassil EVP, Chief Scientific Ofc, COO	Sold10b5-1 plan 2 parts	2,250	$60.90 average	137K	1.5%	Form 4
Oct 5	Jim Wassil EVP, Chief Scientific Ofc, COO	Sold10b5-1 plan	18,000	$86.74	$1.56M	11%	Form 4
Oct 5	Elvia Cowan SVP, Finance & CAO	Sold10b5-1 plan	19,000	$86.74	$1.65M	41%	Form 4
Oct 1	Jim Wassil EVP, Chief Scientific Ofc, COO	Sold10b5-1 plan 2 parts	2,250	$56.67 average	128K	1.5%	Form 4
Sep 4 – 9	Jim Wassil EVP, Chief Scientific Ofc, COO	Sold10b5-1 plan 2 parts	2,715	$60.35 average	164K	1.8%	Form 4
Sep 1	Jim Wassil Chief Operating Officer	Sold10b5-1 plan 4 parts	3,477	$61.08 average	212K	2.2%	Form 4
Aug 5	Harpreet S. Dhaliwal Chief Technical Ops Officer	Sold10b5-1 plan	17,000	$55.00	935K	18%	Form 4
Aug 3	Jim Wassil Chief Operating Officer	Sold10b5-1 plan 2 parts	2,250	$53.86 average	121K	1.4%	Form 4
Aug 3	Andrew Guggenhime President and CFO	Sold10b5-1 plan 2 parts	10,000	$53.89 average	539K	5.6%	Form 4
Jul 27	Grant Pickering Chief Executive Officer	Sold10b5-1 plan 6 parts	18,198	$55.63 average	$1.01M	3.0%	Form 4
Jul 6	Andrew Guggenhime President and CFO	Sold10b5-1 plan 2 parts	10,000	$57.29 average	573K	5.7%	Form 4
Jul 1	Jim Wassil Chief Operating Officer	Sold10b5-1 plan 3 parts	2,250	$56.33 average	127K	1.4%	Form 4
Jun 26	Grant Pickering Chief Executive Officer	Sold10b5-1 plan 9 parts	24,237	$55.22 average	$1.34M	4.0%	Form 4
Jun 18	Grant Pickering Chief Executive Officer	Sold10b5-1 plan 4 parts	24,461	$52.50 average	$1.28M	3.9%	Form 4
Jun 18	Andrew Guggenhime President and CFO	Sold10b5-1 plan	10,000	$53.00	530K	5.7%	Form 4
Jun 1	Jim Wassil Chief Operating Officer	Sold10b5-1 plan 2 parts	2,250	$49.52 average	111K	1.4%	Form 4
May 1	Jim Wassil Chief Operating Officer	Sold10b5-1 plan	2,250	$56.83	128K	1.4%	Form 4
Apr 7	Elvia Cowan SVP, Finance & CAO	Sold10b5-1 plan	3,000	$60.00	180K	9.4%	Form 4
Apr 1	Jim Wassil Chief Operating Officer	Sold10b5-1 plan 2 parts	2,250	$58.43 average	131K	1.4%	Form 4
Mar 17	Elvia Cowan SVP, Finance & CAO	Sold10b5-1 plan 2 parts	1,892	$55.58 average	105K	6.1%	Form 4
Mar 11	Elvia Cowan SVP, Finance & CAO	Sold10b5-1 plan	2,500	$58.59	146K	7.5%	Form 4
Mar 10	Jim Wassil Chief Operating Officer	Sold10b5-1 plan 2 parts	7,395	$58.88 average	435K	4.2%	Form 4
Dec 31, 2025	Harpreet S. Dhaliwal Chief Technical Ops Officer	SoldNo plan	9,743	$46.69	455K	29%	Form 4
Dec 23, 2025	Elvia Cowan SVP, Finance	SoldNo plan 2 parts	11,623	$47.92 average	557K	46%	Form 4
Mar 5, 2025	Mikhail Eydelman SVP, Gen Counsel & Corp Sec	Sold10b5-1 plan 3 parts	5,000	$70.74 average	354K	11%	Form 4
Mar 3, 2025	Jim Wassil Chief Operating Officer	Sold10b5-1 plan 2 parts	8,000	$73.27 average	586K	5.0%	Form 4
Feb 18, 2025	Andrew Guggenhime President and CFO	Sold10b5-1 plan 2 parts	8,000	$83.85 average	671K	6.8%	Form 4
Feb 5, 2025	Mikhail Eydelman SVP, Gen Counsel & Corp Sec	Sold10b5-1 plan 5 parts	5,000	$90.07 average	450K	15%	Form 4
Feb 3, 2025	Jim Wassil Chief Operating Officer	Sold10b5-1 plan 3 parts	8,000	$86.23 average	690K	3.7%	Form 4
Jan 21, 2025	Andrew Guggenhime President and CFO	Sold10b5-1 plan 3 parts	8,000	$86.51 average	692K	6.8%	Form 4
Jan 15, 2025	Teri Loxam Director	Sold10b5-1 plan 8 parts	6,250	$85.11 average	532K	47%	Form 4
Jan 6, 2025	Mikhail Eydelman SVP, Gen Counsel & Corp Sec	Sold10b5-1 plan 3 parts	5,000	$85.58 average	428K	15%	Form 4
Jan 2, 2025	Jim Wassil Chief Operating Officer	Sold10b5-1 plan 3 parts	8,000	$83.66 average	669K	3.7%	Form 4
Dec 18, 2024	Andrew Guggenhime President and CFO	Sold10b5-1 plan 4 parts	8,000	$88.78 average	710K	6.8%	Form 4
Dec 9, 2024	Grant Pickering Chief Executive Officer	Sold10b5-1 plan 4 parts	2,366	$92.24 average	218K	0.4%	Form 4
Dec 5, 2024	Mikhail Eydelman SVP, Gen Counsel & Corp Sec	Sold10b5-1 plan 3 parts	5,000	$91.48 average	457K	15%	Form 4
Dec 2, 2024	Grant Pickering Chief Executive Officer	Sold10b5-1 plan 3 parts	15,000	$92.45 average	$1.39M	2.5%	Form 4
Dec 2, 2024	Jim Wassil Chief Operating Officer	Sold10b5-1 plan 3 parts	8,000	$92.49 average	740K	3.7%	Form 4
Nov 18, 2024	Andrew Guggenhime President and CFO	Sold10b5-1 plan 3 parts	8,000	$85.82 average	687K	6.8%	Form 4

Nov 210b5-1 plan
Elvia Cowan
SVP, Finance & CAO · sold 3,000 at avg $60.92
183K
9.7% of stake
Nov 210b5-1 plan
Jim Wassil
EVP, Chief Scientific Ofc, COO · sold 2,250 at avg $60.90
137K
1.5% of stake
Oct 510b5-1 plan
Jim Wassil
EVP, Chief Scientific Ofc, COO · sold 18,000 at $86.74
$1.56M
11% of stake
Oct 510b5-1 plan
Elvia Cowan
SVP, Finance & CAO · sold 19,000 at $86.74
$1.65M
41% of stake
Oct 110b5-1 plan
Jim Wassil
EVP, Chief Scientific Ofc, COO · sold 2,250 at avg $56.67
128K
1.5% of stake
Sep 4 – 910b5-1 plan
Jim Wassil
EVP, Chief Scientific Ofc, COO · sold 2,715 at avg $60.35
164K
1.8% of stake
Sep 110b5-1 plan
Jim Wassil
Chief Operating Officer · sold 3,477 at avg $61.08
212K
2.2% of stake
Aug 510b5-1 plan
Harpreet S. Dhaliwal
Chief Technical Ops Officer · sold 17,000 at $55.00
935K
18% of stake
Aug 310b5-1 plan
Jim Wassil
Chief Operating Officer · sold 2,250 at avg $53.86
121K
1.4% of stake
Aug 310b5-1 plan
Andrew Guggenhime
President and CFO · sold 10,000 at avg $53.89
539K
5.6% of stake
Jul 2710b5-1 plan
Grant Pickering
Chief Executive Officer · sold 18,198 at avg $55.63
$1.01M
3.0% of stake
Jul 610b5-1 plan
Andrew Guggenhime
President and CFO · sold 10,000 at avg $57.29
573K
5.7% of stake
Jul 110b5-1 plan
Jim Wassil
Chief Operating Officer · sold 2,250 at avg $56.33
127K
1.4% of stake
Jun 2610b5-1 plan
Grant Pickering
Chief Executive Officer · sold 24,237 at avg $55.22
$1.34M
4.0% of stake
Jun 1810b5-1 plan
Grant Pickering
Chief Executive Officer · sold 24,461 at avg $52.50
$1.28M
3.9% of stake
Jun 1810b5-1 plan
Andrew Guggenhime
President and CFO · sold 10,000 at $53.00
530K
5.7% of stake
Jun 110b5-1 plan
Jim Wassil
Chief Operating Officer · sold 2,250 at avg $49.52
111K
1.4% of stake
May 110b5-1 plan
Jim Wassil
Chief Operating Officer · sold 2,250 at $56.83
128K
1.4% of stake
Apr 710b5-1 plan
Elvia Cowan
SVP, Finance & CAO · sold 3,000 at $60.00
180K
9.4% of stake
Apr 110b5-1 plan
Jim Wassil
Chief Operating Officer · sold 2,250 at avg $58.43
131K
1.4% of stake
Mar 1710b5-1 plan
Elvia Cowan
SVP, Finance & CAO · sold 1,892 at avg $55.58
105K
6.1% of stake
Mar 1110b5-1 plan
Elvia Cowan
SVP, Finance & CAO · sold 2,500 at $58.59
146K
7.5% of stake
Mar 1010b5-1 plan
Jim Wassil
Chief Operating Officer · sold 7,395 at avg $58.88
435K
4.2% of stake
Dec 31, 2025No plan
Harpreet S. Dhaliwal
Chief Technical Ops Officer · sold 9,743 at $46.69
455K
29% of stake
Dec 23, 2025No plan
Elvia Cowan
SVP, Finance · sold 11,623 at avg $47.92
557K
46% of stake
Mar 5, 202510b5-1 plan
Mikhail Eydelman
SVP, Gen Counsel & Corp Sec · sold 5,000 at avg $70.74
354K
11% of stake
Mar 3, 202510b5-1 plan
Jim Wassil
Chief Operating Officer · sold 8,000 at avg $73.27
586K
5.0% of stake
Feb 18, 202510b5-1 plan
Andrew Guggenhime
President and CFO · sold 8,000 at avg $83.85
671K
6.8% of stake
Feb 5, 202510b5-1 plan
Mikhail Eydelman
SVP, Gen Counsel & Corp Sec · sold 5,000 at avg $90.07
450K
15% of stake
Feb 3, 202510b5-1 plan
Jim Wassil
Chief Operating Officer · sold 8,000 at avg $86.23
690K
3.7% of stake
Jan 21, 202510b5-1 plan
Andrew Guggenhime
President and CFO · sold 8,000 at avg $86.51
692K
6.8% of stake
Jan 15, 202510b5-1 plan
Teri Loxam
Director · sold 6,250 at avg $85.11
532K
47% of stake
Jan 6, 202510b5-1 plan
Mikhail Eydelman
SVP, Gen Counsel & Corp Sec · sold 5,000 at avg $85.58
428K
15% of stake
Jan 2, 202510b5-1 plan
Jim Wassil
Chief Operating Officer · sold 8,000 at avg $83.66
669K
3.7% of stake
Dec 18, 202410b5-1 plan
Andrew Guggenhime
President and CFO · sold 8,000 at avg $88.78
710K
6.8% of stake
Dec 9, 202410b5-1 plan
Grant Pickering
Chief Executive Officer · sold 2,366 at avg $92.24
218K
0.4% of stake
Dec 5, 202410b5-1 plan
Mikhail Eydelman
SVP, Gen Counsel & Corp Sec · sold 5,000 at avg $91.48
457K
15% of stake
Dec 2, 202410b5-1 plan
Grant Pickering
Chief Executive Officer · sold 15,000 at avg $92.45
$1.39M
2.5% of stake
Dec 2, 202410b5-1 plan
Jim Wassil
Chief Operating Officer · sold 8,000 at avg $92.49
740K
3.7% of stake
Nov 18, 202410b5-1 plan
Andrew Guggenhime
President and CFO · sold 8,000 at avg $85.82
687K
6.8% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch PCVX, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Biological Products, (No Diagnostic Substances) · Pick stocks to compare with PCVX

CompareIntrinsic value

RGNXRegenxbio Inc.

$7.71+1.05%40

FDMT4D Molecular Therapeutics, Inc.

$12.28+2.76%40

AGENAgenus Inc.

$6.97+4.50%46

VXRTVaxart Inc.

$0.40+0.00%84

IOVAIovance Biotherapeutics, Inc.

$8.70-1.47%10

DNAGinkgo Bioworks Holdings Inc.

$11.65+8.27%15

ADMAAdma Biologics Inc.

$10.48-5.67%82

IMCRImmunocore Holdings plc

$29.23-2.66%40

Held by ETFs

PCVX is in 86 US ETFs. The largest of them, with PCVX's weight in each:

Spot a number that looks wrong? Check it in PCVX's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing PCVX

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.